Oxford Immunotec (OXFD) Reports In-Line Q2 EPS

Oxford Immunotec (NASDAQ: OXFD) reported Q2 EPS of ($0.25), in-line with the analyst estimate of ($0.25). Revenue for the quarter came in at $29.3 million versus the consensus estimate of $28.55 million.

For earnings history and earnings-related data on Oxford Immunotec (OXFD) click here.

You May Also Be Interested In

• Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
• X Financial (XYF) Tops Q2 EPS by 438c
• Howmet Aerospace Inc. (HWM) PT Raised to $328 at Bernstein SocGen Group